BCP Dermatological Corporation & Metro Drug Inc. Partnership Made Easy with Dermablend
BCP Dermatological Corporation (BCP) and Metro Drug, Inc. (MDI) have recently signed an agreement last July 20, 2017. It was concluded that MDI will be the exclusive distributor of BCP’s flagship brand, Dermablend which is widely prescribed by Dermatologists, Pediatricians, Ob- Gynecologists and other medical practitioners in the country. The contract signing was attended by Ms. Dina dela Paz Stalder , President and CEO and Ms. Lea Juan , Operations Manager of BCP together with MDI’s Chief Executive Mr. Jojit Aguilar and VP-Finance, Mr. Allan Tanlapco .